“We have the science. Now it’s about infrastructure, education, and delivery,” UTMB’s Dr. Scott Weaver said at gathering of scientists at The University of the West Indies that came together to discuss the resurgence of mosquito-borne illnesses like dengue, chikungunya, and Zika.

Dr. Giulio Taglialatela coauthored an opinion piece for the Houston Chronicle on how “Houston region is positioned to become the global leader in the emerging brain economy.”

UTMB’s innovative uses of AI are featured in this article by VentureBeat. “The data is just sitting out there,” UTMB’s Dr. Peter McCaffrey told VentureBeat. “What I love about this is that AI doesn’t have to do anything superhuman. It’s performing a low intellect task, but at very high volume, and that still provides a lot of value, because we’re constantly finding things that we miss.”

“Despite the progress made, many challenges remain in providing life-saving screening imaging to underserved populations,” said UTMB’s Dr. Lidiya Biltibo at the recent American Roentgen Ray Society annual meeting. Biltibo highlighted the success of UTMB’s mobile mammography van as well as the challenges.

It was the best of times, it was the worst of times when measles began to spread in Texarkana in 1970. The city straddles the state line between Texas and Arkansas and provides a lesson for today on the importance of vaccination, write Drs. Richard Rupp and Megan Berman in their Vaccine Smarts Column.

In his latest column, Dr. Victor S. Sierpina delves into the role of the naturopathic doctor. “Naturopathic Medicine emphasizes prevention, lifestyle counseling, nutrition, botanicals, and other non-invasive, natural methods of care,” Sierpina writes.

"If people would just get the standard vaccination, none of this would be happening," Dr. Scott Weaver tells 4029 News as the Arkansas Department of Health reports the state's first confirmed in-state case of measles transmission of 2025.

“With everything else going on in the world, it can be easy to miss new discoveries in biomedical science,” write Drs. Norbert Herzog and David Niesel in their weekly Medical Discovery News column. Herzog and Niesel go over some of the past year’s biggest breakthroughs.

UTMB’s Dr. Shikha Wadhwani was one of three experts invited to a roundtable discussion organized by MedPage Today to discuss new guidelines released by The Kidney Disease: Improving Global Outcomes group.

“I think a billion-dollar question is: how can we sustainably balance rising drug costs, access to high-cost therapies, and evolving reimbursement models, while maintaining clinical excellence and financial viability?” UTMB’s Michael Eagon tells Becker’s. Eagon was one of 14 executives featured in the article.